Zobrazeno 1 - 10
of 298
pro vyhledávání: '"Nida Sen"'
Autor:
Pulak R. Nath, Mary Maclean, Vijay Nagarajan, Jung Wha Lee, Mehmet Yakin, Aman Kumar, Hadi Nadali, Brian Schmidt, Koray D. Kaya, Shilpa Kodati, Alice Young, Rachel R. Caspi, Jonas J. W. Kuiper, H. Nida Sen
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract Birdshot chorioretinopathy is an inflammatory eye condition strongly associated with MHC-I allele HLA-A29. The striking association with MHC-I suggests involvement of T cells, whereas natural killer (NK) cell involvement remains largely unst
Externí odkaz:
https://doaj.org/article/f81206102c384d35a8236de3f769aa55
Autor:
Aman Kumar, MD, Alexander Zeleny, MD, Sunil Bellur, MD, Natasha Kesav, MD, Enny Oyeniran, MD, Kübra Gul Olke, MD, Susan Vitale, PhD, MHS, Wijak Kongwattananon, MD, H. Nida Sen, MD, MHS, Shilpa Kodati, MD
Publikováno v:
Ophthalmology Science, Vol 4, Iss 6, Pp 100559- (2024)
Objective: To characterize changes in the retinal microvasculature in eyes with birdshot chorioretinopathy (BCR) using OCT angiography (OCTA). Design: Retrospective, observational, single center. Subjects: Twenty-eight patients (53 eyes) with BCR and
Externí odkaz:
https://doaj.org/article/b8f5c5ca6b074907a40c70c66da0c1b7
Autor:
Naira Khachatryan, Gui-Shuang Ying, James T Rosenbaum, Gary N Holland, Maxwell Pistilli, John H. Kempen, Nisha R Acharya, Debra A Goldstein, John H Kempen, Ebenezer Daniel, Jennifer E Thorne, Careen Y Lowder, Teresa L Liesegang, Eric B Suhler, Grace A Levy-Clarke, Robert B Nussenblatt, Tracy Giles, RUSSELL W READ, Yannek I Leiderman, Craig W Newcomb, Nirali P Bhatt, James P Dunn, Asaf Hanish, Kathy J Helzlsouer, Siddharth S Pujari, Teresa Liesegang, Lucia Sobrin, Hosne Begum, Pichaporn Artornsombudh, Jeanine M Buchanich, Terri L Washington, Charles Stephen Foster, Douglas Alan Jabs, Hatice Nida Sen, Kurt A Dreger, Hosne A Begum, Tonetta D Fitzgerald, Srishti Kothari, Abhishek R Payal, Sapna S Gangaputra, Roje Oktay Kaçmaz, Armin Maghsoudlou, Hilkiah K Suga, Clara M Pak, Hilkiah K. Suga, John Caccaviello, C. Stephen Foster, R. Oktay Kaçmaz, Siddharth S. Pujari, Abhishek Payal, Jennifer E. Thorne, Douglas A. Jabs, Kurt A. Dreger, James P. Dunn, Sapna S. Gangaputra, Eric B. Suhler, James T. Rosenbaum, H. Nida Sen, Grace A. Levy-Clarke, Robert B. Nussenblatt, Nirali P. Bhatt, Tonetta D. Fitzgerald, Kathy J. Helzlsouer, Marshall M. Joffe, Jeanine M. Buchanich, Terri L. Washington, Careen Y. Lowder, Gary N. Holland, Nisha R. Acharya, Yannek I. Liederman, Jie Debra A. Goldstein, Debra A. Goldstein, Jie (Jessica) Sun, Russell W. Read, Glenn J. Jaffe, Paul A. Latkany, Janet L. Davis, Sunir J. Garg
Publikováno v:
BMJ Oncology, Vol 2, Iss 1 (2023)
Objective Evaluate the association between cancer incidence and immunosuppressive treatment in patients with ocular inflammatory disease (OID).Methods and analysis We performed a retrospective cohort study of patients from 10 US OID subspecialty prac
Externí odkaz:
https://doaj.org/article/7f7b05e8b97f47209c76fd28322a5d71
Autor:
Matthew McHarg, Yujuan Wang, Mehmet Yakin, Alex Zeleny, Sonny Caplash, H Nida Sen, Shilpa Kodati
Publikováno v:
Journal of Ophthalmic Inflammation and Infection, Vol 12, Iss 1, Pp 1-7 (2022)
Abstract Background Coronavirus disease 2019 (COVID-19) systemic symptoms and sequelae have been studied extensively, but less is known about the characterization, duration, and long-term sequelae of ocular symptoms associated with COVID-19 infection
Externí odkaz:
https://doaj.org/article/c7b96ada6b604d2e927790642a8eaac8
Publikováno v:
Journal of Ophthalmic Inflammation and Infection, Vol 12, Iss 1, Pp 1-7 (2022)
Abstract Background Regional corticosteroid therapy for noninfectious uveitis is well-established but usage patterns have not been studied extensively. This study aims to assess practice patterns of retina and uveitis specialists regarding their pref
Externí odkaz:
https://doaj.org/article/70b33f7973874e0b9d87f824db5c0dde
Autor:
Jonas J.W. Kuiper, PhD, Fleurieke H. Verhagen, MD, PhD, Sanne Hiddingh, MSc, Roos A.W. Wennink, MD, Anna M. Hansen, PhD, Kerry A. Casey, PhD, Imo E. Hoefer, PhD, Saskia Haitjema, PhD, Julia Drylewicz, PhD, Mehmet Yakin, MD, H. Nida Sen, MD, PhD, Timothy R.D. J. Radstake, MD, PhD, Joke H. de Boer, MD, PhD
Publikováno v:
Ophthalmology Science, Vol 2, Iss 3, Pp 100175- (2022)
Purpose: Early identification of patients with noninfectious uveitis requiring steroid-sparing immunomodulatory therapy (IMT) is currently lacking in objective molecular biomarkers. We evaluated the proteomic signature of patients at the onset of dis
Externí odkaz:
https://doaj.org/article/1a5195b0ade9461daf64977b6003d89a
Autor:
David J Wilson, Valérie Touitou, Justine R Smith, Manabu Mochizuki, Hiroshi Takase, Steven Yeh, Alexandra L Farrall, H Nida Sen, Daniel V Vasconcelos-Santos, Joke H de Boer, Ninette H ten Dam-van Loon, Janet L Davis, Anthony J Hall, Mark H B Radford
Publikováno v:
BMJ Open, Vol 12, Iss 7 (2022)
Introduction Vitreoretinal lymphoma is a rare ocular cancer with high morbidity and mortality despite treatment. Diagnosis by cytopathology is often delayed, and various molecular and image-based investigations have been developed. Diverse treatments
Externí odkaz:
https://doaj.org/article/ab57deac2003455d8a5ef6f63e8d062b
Publikováno v:
Taiwan Journal of Ophthalmology, Vol 11, Iss 1, Pp 64-70 (2021)
PURPOSE: This prospective study evaluates whether rituximab is a safe and potentially effective treatment for nonparaneoplastic autoimmune retinopathy (npAIR). MATERIALS AND METHODS: Five npAIR patients were enrolled in a Phase I/II, prospective, non
Externí odkaz:
https://doaj.org/article/14f5abd5c77c4e6497194d5fe948ab39
Publikováno v:
American Journal of Ophthalmology Case Reports, Vol 25, Iss , Pp 101357- (2022)
Purpose: To report a patient with vitreoretinal lymphoma (VRL) secondary to systemic diffuse large B-cell lymphoma, who had two episodes of spontaneous regression. Observations: An 80-year-old Nicaraguan male with a history of treated systemic diffus
Externí odkaz:
https://doaj.org/article/8fcd5c7f6ce1417089743e19e24de57e
Autor:
James Murray, Howard Streicher, Elad Sharon, LeAnne Young, Shanda Finnigan, H Nida Sen, Helen X Chen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Background Programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) inhibitors can cause unique immune-related adverse effects due to non-specific immunological activation. However, less is known about adverse effects of these drugs in the eye
Externí odkaz:
https://doaj.org/article/e84c37578072423f9e2a6d163fec9177